The European Prevention of Alzheimer’s Dementia (EPAD), an EU-funded consortium to advance the testing and development of preventative treatments for Alzheimer’s disease, has published data to help foster research in new treatments for the disease. The data includes cognitive, clinical, neuroimaging, and biomarker data from a longitudinal study of over 2,000 research participants. To make this data available to researchers, EPAD has partnered with the Alzheimer’s Disease Data Initiative’s cloud-based platform.
Image credits: Institut Douglas.
